BloodCare CRE
Overview
The BloodCare CRE aims to develop research capacity and infrastructure to deliver the evidence needed to drive better supportive care and outcomes for people and their families living with blood cancers. The objectives of the CRE include:
- Conduct innovative, high-quality collaborative research
- Promote the effective translation of research into knowledge gain
- Build capacity and capability in the interdisciplinary health research workforce
- Extend existing collaborations
Investigators
- Professor Zoe McQuilten, Principal Investigator (Monash University)
- Professor Erica Wood AO, Chief Investigator (Monash University)
- Professor Claire Rickard, Chief Investigator (University of Queensland)
- Professor Meera Agar, Chief Investigator (University of Technology Sydney)
- Professor Eliza Hawkes, Chief Investigator (Monash University)
- A/Prof Andrea Henden, Chief Investigator (University of Queensland)
- Professor Jason Roberts, Chief Investigator (University of Queensland)
- Professor Dennis Petrie, Chief Investigator (Monash University)
- A/Prof Claudia Rutherford, Chief Investigator (University of Sydney)
- Dr Thao Le, Chief Investigator (Monash University)
Program administration and partners
BloodCare CRE is supported by the invaluable contributions and expertise of our investigator team, consumer partners, working groups, stakeholder advisory committee, and individual health professionals and researchers across Australia.
Our key partners include Australasian Leukaemia and Lymphoma Group, Cancer Symptom Trials, Leukaemia Foundation, Lymphoma Australia, and Myeloma Australia.
Contact Us
Principal Investigator, Professor Zoe McQuilten
zoe.mcquilten@monash.edu
Program Manager, Dr Claire Marceaux
claire.marceaux@monash.edu
Mail
BloodCare CRE Program Manager
c/- Transfusion Research Unit
Monash University
553 St Kilda Road
Melbourne VIC 3004